Related Experiment Video
Updated: May 2, 2026

Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
Design and in vitro characterization of buccoadhesive tablets of timolol maleate
Sachin S Gaikwad1, Shital K Thombre, Yogesh K Kale
1Department of Pharmaceutics, MGV's Pharmacy College , Panchavati, Dist-Nashik, Maharashtra , India .
Objective:
The purpose of this work was to develop and evaluate buccoadhesive tablets of timolol maleate (TM) due to its potential to circumvent the first-pass metabolism and to improve its bioavailability.
Methods:
The tablets were prepared by direct compression using two release modifying polymers, Carbopol 974P (Cp-974p) and sodium alginate (SA). A 3(2) full factorial design was employed to study the effect of independent variables, Cp-974p and SA, in various proportions in percent w/w, which influences the in vitro drug release and bioadhesive strengths. Physicochemical properties of the drug were evaluated by ultraviolet, Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and powder X-ray diffraction (P-XRD). Tablets were evaluated for hardness, thickness, weight variation, drug content, surface pH, swelling index, bioadhesive force and in vitro drug release.
Results:
The FTIR and DSC studies showed no evidence of interactions between drug, polymers and excipients. The P-XRD study revealed that crystallinity of TM remain unchanged in optimized formulation tablet. Formulation F9 achieves an in vitro drug release of 98.967% ± 0.28 at 8 h and a bioadhesive force of 0.088 N ± 0.01211.
Conclusion:
We successfully developed buccal tablet formulations of TM and describe a non-Fickian-type anomalous transport as the release mechanism.
Related Concept Videos
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Alternative Methods
Factors Influencing Drug Absorption: Pharmaceutical Parameters
In Vitro Drug Dissolution: Compendial Testing Models II
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

